Goodwin Biotechnology, a biological contract development and manufacturing organization (CDMO) that specializes in bioprocess development and GMP manufacturing of biopharmaceuticals utilizing mammalian cell culture expression systems and bioconjugation technologies, was selected by Panacea Pharmaceuticals to complete a novel fill/finish project, as well as quality control release and stability testing for a therapeutic, nanoparticle cancer vaccine based on the human Aspartyl (Asparaginyl) β-Hydr...